Oral propranolol decreases intestinal permeability in patients with cirrhosis: another protective mechanism against bleeding?
Senzolo
Marco
M
Fries
W
W
Buda
A
A
Pizzuti
D
D
Nadal
E
E
Sturniolo
G C
GC
Burroughs
A K
AK
D'Incà
R
R
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D018988:Bacterial Translocation / Q000187:drug effects; D002986:Clinical Trials as Topic; D004932:Esophageal and Gastric Varices / Q000150:complications*; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D008103:Liver Cirrhosis / Q000150:complications*; D010538:Peritonitis / Q000517:prevention & control*; D011433:Propranolol / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011433:Propranolol